Imaging Literature and Terminology: When Is It Residual Cancer and When Recurrence?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 1, 2004, Pages 120-121

  Goerres, Gerhard W ^a   Stoeckli, Sandro J ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER RECURRENCE; DIAGNOSTIC IMAGING; DRUG UPTAKE; FOLLOW UP; HEAD CANCER; HUMAN; LETTER; METASTASIS; NECK CANCER; NOMENCLATURE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 0347635291     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.1.120     Document Type: Letter

References (14)

1. Goerres GW, Schmid DT, Bandhauer F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:105-109.
2. Fischbein NJ, AAssar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/ recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 1998;19:1189-1196.
3. Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol. 2002;128:279-282.
4. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer. 2000;36:858-867.
5. Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer. 2001;92:434-439.
6. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin RB, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope. 1995;105:135-139.
7. Pai M, Park CH, Suh JH, Koh JH. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer. Clin Nucl Med. 1999;24:495-500.
8. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18) F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199-4208.
9. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999;26:767-773.
10. Greven KM, Williams DW III, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942-946.
11. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxyglucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001;23:933-941.
12. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M. Pauwels S. Positron emission tomography with fluorodeoxylucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000;110:1493-1497.
13. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope. 1999;109:970-975.
14. Greven KM, Williams DW III, Keyes JW Jr, McGuirt WF, Watson NE Jr, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am. 1997;3:353-357.